Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis
Authors
Keywords
-
Journal
EUROPEAN UROLOGY
Volume 84, Issue 1, Pages 36-48
Publisher
Elsevier BV
Online
2023-04-08
DOI
10.1016/j.eururo.2023.03.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PSMA PET in Imaging Prostate Cancer
- (2022) Ioannis Tsechelidis et al. Frontiers in Oncology
- Imaging of Oligometastatic Disease
- (2022) Naik Vietti Violi et al. Cancers
- E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
- (2021) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
- (2021) Simona Malaspina et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Current and emerging clinical applications of PSMA-PET diagnostic imaging for prostate cancer
- (2021) Andrea Farolfi et al. JOURNAL OF NUCLEAR MEDICINE
- A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate-Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)
- (2021) Kenneth J. Pienta et al. JOURNAL OF UROLOGY
- Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
- (2021) Jeremie Calais et al. BMC CANCER
- Incremental Impact of [68 Ga]Ga-PSMA-11 PET/CT in Primary N and M Staging of Prostate Cancer Prior to Curative-Intent Surgery: a Prospective Clinical Trial in Comparison with mpMRI
- (2021) Florian Szigeti et al. MOLECULAR IMAGING AND BIOLOGY
- Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection
- (2021) Thomas A. Hope et al. JAMA Oncology
- 68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement
- (2021) Mohammadreza Chavoshi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Primary staging in patients with intermediate- and high-risk prostate cancer: Multiparametric MRI and 68Ga-PSMA-PET/MRI – What is the value of quantitative data from multiparametric MRI alone or in conjunction with clinical information?
- (2021) Stephan M Skawran et al. EUROPEAN JOURNAL OF RADIOLOGY
- Comparison of 68Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
- (2021) Julien Van Damme et al. Cancers
- Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and Multiparametric MRI for Pelvic Lymph Node Staging Prior to Radical Prostatectomy in Patients With Intermediate to High-Risk Prostate Cancer: A Meta-Analysis
- (2021) Xueju Wang et al. Frontiers in Oncology
- PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review
- (2020) Lars J. Petersen et al. CANCER IMAGING
- Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?
- (2020) Duygu Has Simsek et al. ANNALS OF NUCLEAR MEDICINE
- Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
- (2020) Michael S Hofman et al. LANCET
- Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings
- (2020) Felipe de Galiza Barbosa et al. CANCER IMAGING
- Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy
- (2020) Helle D. Zacho et al. EJNMMI Research
- Comparison of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and multi-parametric magnetic resonance imaging (MRI) in the evaluation of tumor extension of primary prostate cancer
- (2020) Mengxia Chen et al. Translational Andrology and Urology
- Comparing the Diagnostic Performance of Multiparametric Prostate MRI Versus 68Ga-PSMA PET-CT in the Evaluation Lymph Node Involvement and Extraprostatic Extension
- (2020) Aydan Arslan et al. ACADEMIC RADIOLOGY
- Histological comparison between predictive value of pre-operative 3T multiparametric MRI and 68 Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer
- (2020) A Franklin et al. BJU INTERNATIONAL
- Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
- (2020) B. H. E. Jansen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study
- (2020) Sinan Çelen et al. UROLOGIA INTERNATIONALIS
- A comparison between 68Ga-labeled prostate-specific membrane antigen-PET/CT and multiparametric MRI for excluding regional metastases prior to radical prostatectomy
- (2020) Michael Frumer et al. Abdominal Radiology
- Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy
- (2020) Ersin Koseoglu et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial
- (2020) Rafael E. de Feria Cardet et al. EUROPEAN UROLOGY
- Lymphatic micrometastases predict biochemical recurrence in patients undergoing radical prostatectomy and pelvic lymph node dissection for prostate cancer
- (2019) Andreas Maxeiner et al. AKTUELLE UROLOGIE
- Comparison of preoperative locoregional Ga‐68 PSMA‐11 PET‐CT and mp‐MRI results with postoperative histopathology of prostate cancer
- (2019) Burcak Yilmaz et al. PROSTATE
- Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis
- (2019) Jing Zhou et al. SKELETAL RADIOLOGY
- 68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study
- (2019) Lars J. Petersen et al. WORLD JOURNAL OF UROLOGY
- Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers—Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT
- (2019) Rudolf A. Werner et al. Journal of Clinical Medicine
- Prospective Validation of Gallium-68 PSMA-PET/CT in Primary Staging of Prostate Cancer Patients
- (2019) L.W.M. van Kalmthout et al. JOURNAL OF UROLOGY
- Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer
- (2019) Urs J. Muehlematter et al. RADIOLOGY
- In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen PET computed tomography?
- (2019) Smita Chinmay Kulkarni et al. NUCLEAR MEDICINE COMMUNICATIONS
- Histologically-confirmed diagnostic efficacy of 18F-rhPSMA-7 positron emission tomography for N-staging of patients with primary high risk prostate cancer
- (2019) Markus Krönke et al. JOURNAL OF NUCLEAR MEDICINE
- 68 GaPSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
- (2018) Thabo Lengana et al. Clinical Genitourinary Cancer
- 68Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology
- (2018) I. Berger et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer
- (2018) Sonya Youngju Park et al. RADIOLOGY
- 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review
- (2018) Julia Corfield et al. WORLD JOURNAL OF UROLOGY
- 68Ga PSMA PET/CT predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate and high-risk prostate cancer
- (2018) Pim J. van Leeuwen et al. BJU INTERNATIONAL
- 68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery
- (2018) Rohan Nandurkar et al. BRITISH JOURNAL OF RADIOLOGY
- The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer
- (2017) Can Öbek et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT
- (2017) Jan-Carlo Janssen et al. EUROPEAN RADIOLOGY
- Seduction by Sensitivity: Reality, Illusion, or Delusion? The Challenge of Assessing Outcomes after PSMA Imaging Selection of Patients for Treatment
- (2017) Rodney J. Hicks et al. JOURNAL OF NUCLEAR MEDICINE
- Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumor Burden in Prostate Cancer Using68Ga-PSMA PET/CT
- (2017) Marie Bieth et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer
- (2017) Qing Zhang et al. Journal of Translational Medicine
- Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer
- (2016) Thomas Pyka et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
- (2016) Tobias Maurer et al. JOURNAL OF UROLOGY
- Empirical Evidence of the Importance of Comparative Studies of Diagnostic Test Accuracy
- (2013) Yemisi Takwoingi et al. ANNALS OF INTERNAL MEDICINE
- Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
- (2013) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- On fitting generalized linear mixed-effects models for binary responses using different statistical packages
- (2011) Hui Zhang et al. STATISTICS IN MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started